Loading...
Molecular biomarkers in early stage lung cancer
Low dose computed tomography (LDCT) screening, together with the recent advances in targeted and immunotherapies, have shown to improve non-small cell lung cancer (NSCLC) survival. Furthermore, screening has increased the number of early stage-detected tumors, allowing for surgical resection and mul...
Na minha lista:
| Udgivet i: | Transl Lung Cancer Res |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AME Publishing Company
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7947407/ https://ncbi.nlm.nih.gov/pubmed/33718054 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-20-750 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|